Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2)

摘要

Pharmaceutical compositions and methods for the treatment of DENND1A.V2 related disorders, such as PCOS, are provided. In particular, humanized and mouse monoclonal antibodies specific for DENND1A.V2 and methods for using the same are provided.